SEMA4D and colorectal carcinoma: PLXNB1 expression was not found to be significantly associated with the overall survival of CRC patients (Figure 5D, Figure S2), whereas patients with high SEMA4D expression had a significantly poorer survival rate (Figure 5E; Figure S2).